» Authors » Alessandro Serino

Alessandro Serino

Explore the profile of Alessandro Serino including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 17
Citations 221
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Luzzago S, Serino A, Aurilio G, Mistretta F, Piccinelli M, Lorusso V, et al.
Urol Oncol . 2021 Jul; 39(10):736.e1-736.e7. PMID: 34301457
Purpose: To report long-term oncological outcomes after penile-sparing surgery (PSS) for superficial (Ta-Tis) or initially invasive (T1) penile cancer patients. Methods: We retrospectively analysed 85 patients with Ta/Tis/T1cN0cM0 penile cancer...
2.
Musi G, Cozzi G, Mistretta F, Tringali V, Serino A, Jereczek-Fossa B, et al.
Andrologia . 2020 May; 52(6):e13613. PMID: 32352182
We aimed to assess the incidence of prosthesis-related complications in patients who received a testicular prosthesis at the time of radical orchiectomy for testicular cancer and were then treated with...
3.
Luzzago S, Petralia G, Musi G, Catellani M, Alessi S, Di Trapani E, et al.
Clin Genitourin Cancer . 2018 Dec; 17(2):88-96. PMID: 30527286
Purpose: To understand the multiparametric magnetic resonance imaging (mpMRI) interreader agreement between radiologists of peripheral and academic centers and the possibility to avoid prostate biopsies according to magnetic resonance imaging...
4.
Ferro M, Di Lorenzo G, de Cobelli O, Bruzzese D, Pignataro P, Borghesi M, et al.
World J Urol . 2018 Dec; 37(6):1049-1059. PMID: 30519742
Background: Cancer-related fatigue (CRF) is a complex condition that is reported in > 50% of cancer patients. In men with castration-resistant prostate cancer (CRPC), CRF was reported in 12-21% of...
5.
Ferro M, Musi G, Serino A, Cozzi G, Mistretta F, Costa B, et al.
Urol Int . 2018 Nov; 102(1):43-50. PMID: 30408799
Background: Several biochemical and clinical markers have been proposed for selecting patients for active surveillance (AS). However, some of these are expensive and not easily accessible. Moreover, currently about 30%...
6.
Vartolomei M, Matei D, Renne G, Tringali V, Crisan N, Musi G, et al.
Minerva Urol Nefrol . 2018 Sep; 71(1):31-37. PMID: 30230293
Background: The aim of this study was to assess the long-term oncologic and functional outcomes in elderly patients having undergone robot-assisted partial nephrectomy (RAPN) for renal cancer (RC). Methods: Sixty-one...
7.
Capogrosso P, Ventimiglia E, Boeri L, Serino A, Russo A, La Croce G, et al.
Expert Rev Clin Pharmacol . 2017 Jan; 10(3):339-344. PMID: 28129714
Background: A rapid onset of action for phosphodiesterase type 5 inhibitors (PDE5is) emerged to be of clinical importance in men treated for erectile dysfunction (ED). Data from randomized clinical trials...
8.
Bianchi R, Cozzi G, Petralia G, Alessi S, Renne G, Bottero D, et al.
Medicine (Baltimore) . 2016 Oct; 95(40):e4519. PMID: 27749525
To evaluate the role of multiparametric magnetic resonance imaging (mpMRI) in predicting upgrading, upstaging, and extraprostatic extension in patients with low-risk prostate cancer (PCa). MpMRI may reduce positive surgical margins...
9.
Ferro M, Bottero D, DElia C, Matei D, Cioffi A, Cozzi G, et al.
BJU Int . 2016 Oct; 119(3):482-488. PMID: 27696622
Objective: To evaluate the efficacy and safety of the Virtue male sling (Coloplast, Humlebaek, Denmark) in a cohort of patients affected by post-prostatectomy stress urinary incontinence (SUI). Methods: All 29...
10.
Ferro M, Terracciano D, Buonerba C, Lucarelli G, Bottero D, Perdona S, et al.
Future Oncol . 2016 Sep; 13(3):285-293. PMID: 27624840
Obesity is associated with an increased risk of a number of serious medical conditions, including cancer. As far as prostate cancer is concerned, obesity is associated with an increased risk...